4
MARKET OVERVIEW
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
4.2.1.1
EUROPE'S AGING POPULATION STRAINING HEALTHCARE SYSTEM CAPACITY
4.2.1.2
EU-WIDE DIGITAL HEALTH INFRASTRUCTURE INITIATIVES
4.2.1.3
PUBLIC HEALTH SYSTEMS SEEKING REMOTE MONITORING COST SAVINGS
4.2.1.4
EVOLVING REIMBURSEMENT MODELS BOOSTING DIGITAL CARE UPTAKE
4.2.2.1
FRAGMENTED REIMBURSEMENT MODELS ACROSS 27 MEMBER STATES
4.2.2.2
MDR COMPLIANCE COSTS EXTENDING VENDOR TIME-TO-MARKET
4.2.2.3
LEGACY EHR VARIABILITY HINDERING SEAMLESS RPM INTEROPERABILITY
4.2.3.1
NEXTGENERATIONEU RECOVERY FUND SUPPORTING DIGITAL HEALTH INVESTMENT
4.2.3.2
DATA INTEGRATION PLATFORMS EMERGING AS STRATEGIC DIFFERENTIATORS
4.2.4.1
NEED FOR COUNTRY-SPECIFIC CLINICAL AND ECONOMIC VALIDATION
4.2.4.2
COMPLEX MULTILAYER COMPLIANCE UNDER MDR AND AI ACT
4.2.4.3
HIGH INTEGRATION BURDEN ACROSS EUROPE’S FRAGMENTED HEALTH IT
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.2.3
TRENDS IN HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR EUROPE REMOTE PATIENT MONITORING SOLUTIONS, BY KEY PLAYER (2024)
5.5.2
INDICATIVE PRICE FOR EUROPE REMOTE PATIENT MONITORING SOLUTIONS, BY COUNTRY (2024)
5.7
KEY CONFERENCES & EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9
INVESTMENT & FUNDING SCENARIO
5.11
IMPACT OF 2025 US TARIFFS ON EUROPE REMOTE PATIENT MONITORING MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON REMOTE PATIENT MONITORING
6.6.1
TOP USE CASES & MARKET POTENTIAL
6.6.2
BEST PRACTICES IN REMOTE PATIENT MONITORING
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN REMOTE PATIENT MONITORING MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MARKET
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
9.2.1.1
CARDIAC MONITORING DEVICES
9.2.1.2
NEUROLOGICAL MONITORING DEVICES
9.2.1.3
RESPIRATORY MONITORING DEVICES
9.2.1.4
BLOOD GLUCOSE MONITORING DEVICES
9.2.1.5
FETAL & NEONATAL MONITORING DEVICES
9.2.1.6
WEIGHT MONITORING DEVICES
9.2.1.7
MULTIPARAMETER MONITORING DEVICES
9.2.1.8
PULSE OXIMETER DEVICES
9.2.1.10
OTHER MONITORING DEVICES (REHABILITATION AND PHYSICAL THERAPY DEVICES, FALL DETECTION DEVICES, AND OTHERS)
9.2.2.2
IMPLANTABLE DEVICES
9.2.2.3
HANDHELD & PORTABLE DEVICES
9.2.2.4
OTHERS (STATIONARY DEVICES, AND OTHERS)
9.3.1
BY DEPLOYMENT MODEL
9.3.1.2
CLOUD-BASED MODEL
9.3.2
BY TRANSMISSION TYPE
10
EUROPE REMOTE PATIENT MONITORING MARKET, BY INDICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
10.7
RESPIRATORY DISEASES
10.8
WELLNESS IMPROVEMENT (WEIGHT MANAGEMENT, FITNESS MONITORING, HYDRATION MONITORING, NUTRITIONAL TRACKING & MONITORING, ETC.)
10.10
OTHERS (OBSTETRICS & GYNECOLOGY, IMMUNOLOGY, INFECTIOUS DISEASES, METABOLIC DISORDERS, OPHTHALMOLOGY, GASTROENTEROLOGY, NEPHROLOGY & UROLOGY, HEMATOLOGY, ENDOCRINOLOGY, MUSCULOSKELETAL DISORDERS, AND OTHERS)
11
EUROPE REMOTE PATIENT MONITORING MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
11.2
HEALTHCARE PROVIDERS
11.2.2
AMBULATORY SURGICAL CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
11.2.3
LONG-TERM CARE & ASSISTED LIVING FACILITIES
11.2.5
OTHER HEALTHCARE PROVIDERS (DIAGNOSTICS & IMAGING CENTERS, REHABILITATION CENTERS, BEHAVIOURAL HEALTH CENTERS, AND OTHERS)
11.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.7
OTHER END USERS (EMPLOYER GROUPS, GOVERNMENT ORGANIZATIONS, ACADEMIC INSTITUTES, RESEARCH CENTERS, AND OTHERS)
12
EUROPE REMOTE PATIENT MONITORING MARKET, BY COUNTRY (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2020–2024
13.4
MARKET SHARE ANALYSIS,
13.5
BRAND/SOFTWARE COMPARISON
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.6.5.1
COMPONENT FOOTPRINT
13.6.5.2
INDICATION FOOTPRINT
13.6.5.3
END-USER FOOTPRINT
13.7
COMPANY EVAULATION MATRIX: STARTUPS/SMES,
13.7.1
PROGRESSIVE COMPANIES
13.7.3
RESPONSIVE COMPANIES
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.8
COMPANY VALUATION & FINANCIAL METRICS
13.9
COMPETITIVE SCENARIO
13.9.1
PRODUCT LAUNCHES & UPGRADES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE EUROPE REMOTE PATIENT MONITORING MARKET LANDSCAPE
14.1.1
KONINKLIJKE PHILIPS N.V.
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
15.1.1.3.1
KEY STRENGTHS/RIGHT TO WIN
15.1.1.3.2
STRATEGIC CHOICES
15.1.1.3.3
WEAKNESSES & COMPETITIVE THREATS
14.1.6
BOSTON SCIENTIFIC CORPORATION
14.1.8
NIHON KOHDEN CORPORATION
14.1.9
SIEMENS HEALTHINEERS
14.1.10
BAXTER INTERNATIONAL
14.1.13
TELADOC HEALTH, INC
14.1.16
F. HOFFMANN-LA ROCHE LTD.
14.1.18
BEIJING CHOICE ELECTRONIC TECH CO., LTD.
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY PRIMARY PARTICIPANTS
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.4
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.2.1
BOTTOM-UP APPROACH
15.2.3
BASE NUMBER CALCULATION
15.3
MARKET FORECAST APPROACH
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Remote Patient Monitoring (RPM) Market